Sarepta Therapeutics, Inc. (SRPT)
17.55
-1.13
(-6.05%)
USD |
NASDAQ |
May 15, 16:00
17.90
+0.35
(+1.99%)
After-Hours: 20:00
Sarepta Therapeutics Shareholders Equity (Quarterly) : 1.505B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -180.46M |
| Keros Therapeutics, Inc. | 285.63M |
| REGENXBIO, Inc. | 21.08M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Cytokinetics, Inc. | -826.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.179B |
| Total Liabilities (Quarterly) | 1.674B |
| Debt to Equity Ratio | 0.6888 |
| Current Ratio | 4.628 |
| Net Debt Paydown Yield | 2.67% |